Wolkowitz OM - Search Results

1

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.

Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Kramer J, Jagust W, Miller B, Wolkowitz OM, Yaffe K, Weiner MW. Schuff N, et al. Among authors: wolkowitz om. Neurology. 2002 Mar 26;58(6):928-35. doi: 10.1212/wnl.58.6.928. Neurology. 2002. PMID: 11914410 Free PMC article.

2

Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients.

Chao LL, Schuff N, Kramer JH, Du AT, Capizzano AA, O'Neill J, Wolkowitz OM, Jagust WJ, Chui HC, Miller BL, Yaffe K, Weiner MW. Chao LL, et al. Among authors: wolkowitz om. Neurology. 2005 Jan 25;64(2):282-9. doi: 10.1212/01.WNL.0000149638.45635.FF. Neurology. 2005. PMID: 15668426 Free PMC article.

3

DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study.

Wolkowitz OM, Kramer JH, Reus VI, Costa MM, Yaffe K, Walton P, Raskind M, Peskind E, Newhouse P, Sack D, De Souza E, Sadowsky C, Roberts E; DHEA-Alzheimer's Disease Collaborative Research. Wolkowitz OM, et al. Neurology. 2003 Apr 8;60(7):1071-6. doi: 10.1212/01.wnl.0000052994.54660.58. Neurology. 2003. PMID: 12682308 Clinical Trial.

4

MRI deep white matter hyperintensity in a psychiatric population.

Deicken RF, Reus VI, Manfredi L, Wolkowitz OM. Deicken RF, et al. Among authors: wolkowitz om. Biol Psychiatry. 1991 May 1;29(9):918-22. doi: 10.1016/0006-3223(91)90058-t. Biol Psychiatry. 1991. PMID: 2049490

5

Dehydroepiandrosterone (DHEA) treatment of depression.

Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Wolkowitz OM, et al. Biol Psychiatry. 1997 Feb 1;41(3):311-8. doi: 10.1016/s0006-3223(96)00043-1. Biol Psychiatry. 1997. PMID: 9024954 Clinical Trial.

6

Double-blind treatment of major depression with dehydroepiandrosterone.

Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E. Wolkowitz OM, et al. Am J Psychiatry. 1999 Apr;156(4):646-9. doi: 10.1176/ajp.156.4.646. Am J Psychiatry. 1999. PMID: 10200751 Clinical Trial.

7

Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients.

Harris DS, Wolkowitz OM, Reus VI. Harris DS, et al. Among authors: wolkowitz om. World J Biol Psychiatry. 2001 Apr;2(2):99-102. doi: 10.3109/15622970109027500. World J Biol Psychiatry. 2001. PMID: 12587192

8

Antidepressant and cognition-enhancing effects of DHEA in major depression.

Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Wolkowitz OM, et al. Ann N Y Acad Sci. 1995 Dec 29;774:337-9. doi: 10.1111/j.1749-6632.1995.tb17403.x-i1. Ann N Y Acad Sci. 1995. PMID: 8597481 No abstract available.

9

Antiglucocorticoid treatments in psychiatry.

Reus VI, Wolkowitz OM, Frederick S. Reus VI, et al. Among authors: wolkowitz om. Psychoneuroendocrinology. 1997;22 Suppl 1:S121-4. doi: 10.1016/s0306-4530(97)00016-4. Psychoneuroendocrinology. 1997. PMID: 9264158 Review.

10

Antiglucocorticoid treatment of depression: double-blind ketoconazole.

Wolkowitz OM, Reus VI, Chan T, Manfredi F, Raum W, Johnson R, Canick J. Wolkowitz OM, et al. Biol Psychiatry. 1999 Apr 15;45(8):1070-4. doi: 10.1016/s0006-3223(98)00267-4. Biol Psychiatry. 1999. PMID: 10386195 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters